Research activity and capability in the European reference network MetabERN-Reference-Cited by-同舟云学术

Research activity and capability in the European reference network MetabERN

Published:2019-05-29 Issue:1 Volume:14 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Heard Jean-Michel^ORCID, ,Bellettato Cinzia,van Lingen Corine,Scarpa Maurizio

Funder

Third Health Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-019-1091-8.pdf

Reference19 articles.

1. Directive 2011/24/EU of the European Parliament and of the council of 9 march 2011 on the application of patients’ rights in cross-border healthcare http://data.europa.eu/eli/dir/2011/24/oj

2. Heon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137.

3. Hannemann-Weber H, Kessel M, Schultz C. Research performance of centers of expertise for rare diseases--the influence of network integration, internal resource access and operational experience. Health Policy. 2011;105:138–45.

4. Ayme S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50:1477–83.

5. Ferreira C, van Karnebeek C, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2019;21:102–6.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products;Value in Health;2021-02

2. Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network;Orphanet Journal of Rare Diseases;2020-01-06